Concurrent cetuximab, cisplatin, and concomitant boost radiotherapy for locoregionally advanced, squamous cell head and neck cancer: a pilot phase II study of a new combined-modality paradigm

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
David G PfisterMichael J Zelefsky

Abstract

Cetuximab is a chimeric monoclonal antibody that targets the epidermal growth factor receptor. Cetuximab has activity in squamous cell carcinoma and enhances both chemotherapy and radiotherapy. We conducted a pilot phase II study of a new combined-modality paradigm of targeted therapy (cetuximab) with chemoradiotherapy. Eligible patients had stage III or IV, M0, squamous cell head and neck cancer. Treatment included concomitant boost radiotherapy (1.8 Gy/d weeks 1 to 6; boost: 1.6 Gy 4 to 6 hours later weeks 5 to 6; 70 Gy total to gross disease), cisplatin (100 mg/m2 intravenously weeks 1 and 4), and cetuximab (400 mg/m2 intravenously week 1, followed by 250 mg/m2 weeks 2 to 10). Twenty-two patients were enrolled (median age, 57 years; range, 41 to 72 years; median Karnofsky status, 90%; range, 70% to 90%; oropharynx primary tumor, 59% of patients; T4, 36%; N2/3, 77%; stage IV disease, 86%). One patient did not receive study treatment because of an ineligible diagnosis. The severity of expected, acute toxicities was typical of concurrent cisplatin and radiotherapy alone. Grade 3 or 4 cetuximab-related toxicities included acne-like rash (10%) and hypersensitivity (5%). However, the study was closed for significant adverse events...Continue Reading

References

Oct 1, 1991·Clinical Otolaryngology and Allied Sciences·M MiyaguchiH B Hellquist
Aug 1, 1991·International Journal of Radiation Oncology, Biology, Physics·L H PintoL Souhami
Jun 13, 1991·The New England Journal of Medicine·UNKNOWN Department of Veterans Affairs Laryngeal Cancer Study GroupWilliam G Henderson
Sep 1, 1990·Acta Oto-laryngologica·M MiyaguchiH B Hellquist
Dec 1, 1990·International Journal of Radiation Oncology, Biology, Physics·K K AngB W Brown
Mar 1, 1983·Proceedings of the National Academy of Sciences of the United States of America·T KawamotoJ Mendelsohn
Oct 1, 1993·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·O DassonvilleG Milano
Mar 1, 1993·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D F CellaJ Brannon
Mar 5, 1997·Journal of the National Cancer Institute·J Mendelsohn, Z Fan
Apr 29, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·T G WendtA Schalhorn
Jun 13, 1998·Journal of the National Cancer Institute·J Rubin GrandisD J Tweardy
Feb 16, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J BaselgaJ Mendelsohn
Mar 29, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·B JeremicL Tadic
Jun 13, 2000·Cancer Biotherapy & Radiopharmaceuticals·M N SalehD J Buchsbaum
Jul 4, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·F RobertH W Waksal
Dec 31, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·David J AdelsteinArlene A Forastiere
Jul 6, 2004·International Journal of Radiation Oncology, Biology, Physics·Eiko NakataLuka Milas
Nov 30, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Barbara BurtnessUNKNOWN Eastern Cooperative Oncology Group

❮ Previous
Next ❯

Citations

Sep 18, 2009·Cancer Chemotherapy and Pharmacology·Yunfei CaoFeng Gao
Apr 20, 2007·International Journal of Clinical Oncology·Juliette ThariatK Kian Ang
Oct 27, 2007·Current Treatment Options in Oncology·Keisuke Shirai, Paul E O'Brien
Sep 26, 2013·Current Treatment Options in Oncology·Nerina DenaroMarco C Merlano
Apr 2, 2008·Current Oncology Reports·Ranee MehraPaul M Harari
Feb 27, 2013·Drugs·Kelly Dorsey, Mark Agulnik
Apr 25, 2009·Nature Reviews. Clinical Oncology·Jacques BernierJan B Vermorken
Mar 3, 2011·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A ArgirisD E Heron
Sep 29, 2011·Annals of Oncology : Official Journal of the European Society for Medical Oncology·B B Y MaA T C Chan
Oct 6, 2009·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·Maya GuglinAnne B Curtis
Jul 1, 2011·Japanese Journal of Clinical Oncology·Akihiro HommaSatoshi Fukuda
Jan 8, 2008·Anti-cancer Drugs·Fernando RiveraMarta Francisca López-Brea
Nov 5, 2010·Anti-cancer Drugs·Jean-Pascal Machiels, Sandra Schmitz
Apr 7, 2007·Current Opinion in Oncology·Hwan Jung YunDenis Lacombe
Apr 7, 2007·Current Opinion in Oncology·Pol Specenier, Jan B Vermorken
Mar 2, 2011·Current Opinion in Oncology·Jean-Pascal Machiels, Sandra Schmitz
Apr 9, 2008·American Journal of Clinical Oncology·Stephanie A TerezakisNancy Y Lee
Sep 30, 2009·American Journal of Clinical Oncology·Ariel BirnbaumTerence Tai-Weng Sio
Mar 5, 2011·Current Opinion in Otolaryngology & Head and Neck Surgery·Lisa LicitraRoberta Granata
Aug 30, 2008·Annual Review of Pathology·Sara I Pai, William H Westra
Nov 15, 2012·Chemotherapy Research and Practice·Jeffery S Russell, A Dimitrios Colevas
Jan 25, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jill GilbertMaura Gillison
Oct 19, 2006·Radiation Oncology·Maximilian Niyazi, Claus Belka
Dec 23, 2011·Radiation Oncology·Maximilian NiyaziClaus Belka
Aug 18, 2009·Journal of Experimental & Clinical Cancer Research : CR·Jeffrey B HoagMark E Lund
May 26, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ezra E W CohenEverett E Vokes
Aug 19, 2010·Circulation Journal : Official Journal of the Japanese Circulation Society·Manabu MinamiHisanori Horiuchi
Aug 18, 2010·Biologics : Targets & Therapy·Mohamedtaki A TejaniRanee Mehra
Jan 1, 2009·OncoTargets and Therapy·Francesco PerriFrancesco Caponigro
Mar 30, 2011·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·James E Frampton
Aug 23, 2006·Future Oncology·Ricardo HittManuel Hidalgo
Jul 9, 2011·European Archives of Oto-rhino-laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery·Stijn KeereweerEsther van Meerten

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Atrial Filbrillation

Atrial fibrillation refers to the abnormal heart rhythm characterized by rapid and irregular beating of the atria. Here is the latest research.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Carcinoma, Squamous Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.